Volume | 43,491 |
|
|||||
News | - | ||||||
Day High | 0.9136 | Low High |
|||||
Day Low | 0.81 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Accelerate Diagnostics Inc | AXDX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.9101 | 0.81 | 0.9136 | 0.8159 | 0.91 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
264 | 43,491 | $ 0.8594693 | $ 37,379 | - | 0.81 - 11.90 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:29:10 | formt | 335 | $ 0.8415 | USD |
Accelerate Diagnostics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
12.08M | 14.55M | - | 12.75M | -62.49M | -4.29 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Accelerate Diagnostics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AXDX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.89 | 0.95 | 0.81 | 0.8812837 | 50,596 | -0.0485 | -5.45% |
1 Month | 0.9875 | 1.0899 | 0.81 | 0.9249449 | 76,703 | -0.146 | -14.78% |
3 Months | 1.26 | 1.47 | 0.81 | 1.11 | 89,679 | -0.4185 | -33.21% |
6 Months | 5.87 | 6.39 | 0.81 | 1.83 | 82,925 | -5.03 | -85.66% |
1 Year | 6.889 | 11.90 | 0.81 | 5.48 | 105,063 | -6.05 | -87.78% |
3 Years | 81.90 | 93.60 | 0.81 | 21.46 | 362,447 | -81.06 | -98.97% |
5 Years | 190.80 | 240.00 | 0.81 | 61.69 | 348,516 | -189.96 | -99.56% |
Accelerate Diagnostics Description
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. |